Product Specifications: Lyophilized Powder (>99% purity) in 3ml vial. *Requires Reconstitution ** Available for bulk custom order with 57 Cap/Crimp colors to choose from.
Application: Research peptide bioregulator studied for healing, cardiovascular health, neurological repair, cancer treatment, and anti-inflamation.
Chemical Formula: C8H8O3
Molecular Weight: ~152.15 g/mol
Concentration: ≥99%
Primary Research Areas
Wound Healing
Vilon demonstrates significant potential in wound healing applications. Research indicates that it:
- Accelerates the wound healing process
- Promotes collagen synthesis, which is essential for tissue strength
- Enhances tissue regeneration
- Improves overall wound strength and integrity
Cardiovascular Health
Studies focusing on Vilon's cardiovascular benefits suggest it may:
- Help reduce blood pressure in hypertensive conditions
- Improve lipid profiles, potentially lowering cholesterol levels
- Contribute to the prevention of cardiovascular disease
Neurological Disorders
Vilon exhibits neuroprotective properties that make it a candidate for treating:
- Alzheimer's disease
- Parkinson's disease
- Stroke-related damage
- Other neurodegenerative conditions
Cancer Treatment
As an adjunct therapy in oncology, Vilon is being researched for its ability to:
- Inhibit tumor growth through various mechanisms
- Induce apoptosis (programmed cell death) in cancer cells
- Complement existing cancer treatment protocols
Inflammatory Diseases
Due to its anti-inflammatory properties, Vilon shows promise for treating:
- Arthritis and joint inflammation
- Asthma and respiratory inflammatory conditions
- Various other inflammatory disorders
General Research Focus
The overarching focus of Vilon research is centered on three key therapeutic mechanisms:
- Promotion of tissue repair and regeneration
- Reduction of inflammation in multiple body systems
- Improvement of overall health outcomes across various medical conditions
References:
Gavrisheva, N. A., Malinin, V. V., Ses, T. P., Kozlov, K. L., Panchenko, A. V., & Titkov, A. Y. (2005). Effect of peptide Vilon on the content of transforming growth factor-β and permeability of microvessels during experimental chronic renal failure. Bulletin of Experimental Biology and Medicine, 139, 24-26. https://doi.org/10.1007/s10517-005-0202-9
Avolio, F., Martinotti, S., Khavinson, V. K., Esposito, J. E., Giambuzzi, G., Marino, A., Mironova, E., Pulcini, R., Robuffo, I., Bologna, G., Simeone, P., Lanuti, P., Guarnieri, S., Trofimova, S., Procopio, A. D., & Toniato, E. (2022). Peptides regulating proliferative activity and inflammatory pathways in the monocyte/macrophage THP-1 cell line. International Journal of Molecular Sciences, 23(7), 3607. https://doi.org/10.3390/ijms23073607
Khavinson, V. K., Kuznik, B. I., & Ryzhak, G. A. (2013). [Peptide bioregulators: The new class of geroprotectors. Message 2. Clinical studies results]. Advances in Gerontology, 26(1), 20-37.
Disclaimer: This product is intended solely for laboratory research purposes. It is not suitable for consumption by humans, nor for medical, veterinary, or household purposes. Researchers should handle all peptides with care and adhere to strict safety guidelines during experiments. Only qualified professionals with appropriate expertise should manage and handle this product. The distributor, manufacturer, and seller of this product are not responsible for misuse or any resulting consequences. By accessing this product, you consent to comply with these terms and conditions.
